1. Home
  2. CYTK vs SBSW Comparison

CYTK vs SBSW Comparison

Compare CYTK & SBSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.09

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo D/B/A Sibanye-Stillwater Limited ADS

SBSW

D/B/A Sibanye-Stillwater Limited ADS

HOLD

Current Price

$11.55

Market Cap

9.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
SBSW
Founded
1997
2013
Country
United States
South Africa
Employees
N/A
72423
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
9.4B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
SBSW
Price
$63.09
$11.55
Analyst Decision
Strong Buy
Buy
Analyst Count
18
4
Target Price
$88.50
$16.28
AVG Volume (30 Days)
1.8M
5.6M
Earning Date
05-05-2026
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,368,000.00
N/A
Revenue This Year
$9.79
$36.16
Revenue Next Year
$302.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.31
$3.18
52 Week High
$70.98
$21.29

Technical Indicators

Market Signals
Indicator
CYTK
SBSW
Relative Strength Index (RSI) 50.44 31.30
Support Level $59.25 $10.36
Resistance Level $65.27 $11.89
Average True Range (ATR) 2.51 0.66
MACD 0.04 -0.29
Stochastic Oscillator 73.68 11.63

Price Performance

Historical Comparison
CYTK
SBSW

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

Share on Social Networks: